Skip to main content

Advertisement

ADVERTISEMENT

Volume 33 - Issue 11 - November, 2021

11/01/2021
JIC November 2021 Table of Contents and Entire Issue PDF
JIC November 2021 Table of Contents and Entire Issue PDF
JIC November 2021 Table of...
11/01/2021
Journal of Invasive Cardiology

Feature

Original Contribution
11/01/2021

Luca Mariani, MD, PhD1; Francesco Burzotta, MD, PhD2; Cristina Aurigemma, MD, PhD2; Giancarla Scalone, MD, PhD1; Francesco Fracassi, MD2; Giampaolo Niccoli, MD, PhD2; Rocco Vergallo, MD2; Andrea Romano, MD2; Alessandro Aimi, MD1; Luca Di Vito, MD, PhD1; Simona Silenzi, MD1; Pierfrancesco Grossi, MD1; Carlo Trani, MD2; Filippo Crea, MD2

Luca Mariani, MD, PhD1; Francesco Bur...
Dr. Mariani and colleagues retrospectively evaluated 70 plaques with PR at the FD-OCT (25 in stable CAD patients and 45 in NSTEMI patients). Main clinical, angiographic, and morphological features were compared.
Dr. Mariani and colleagues retrospectively evaluated 70 plaques with PR at the FD-OCT (25 in stable CAD patients and 45 in NSTEMI patients). Main clinical, angiographic, and morphological features were compared.
Dr. Mariani and colleagues...
11/01/2021
Journal of Invasive Cardiology
Original Contribution
11/01/2021

Steven J. Filby, MD1; Luis Augusto Palma Dallan, MD, PhD1; Anthony Cochet, MD1; Akihiro Kobayashi, MD1; Guilherme F. Attizzani, MD1; Imran Rashid, MD1; Sanjay Rajagopalan, MD1; Mauricio Arruda, MD1; Mehdi H. Shishehbor, DO, MPH, PhD1; Hiram G. Bezerra, MD, PhD2

Steven J. Filby, MD1; Luis Augusto Pa...
A prospective analysis of 71 non-consecutive patients who underwent LAAO over an 18-month period with cardiac CTA-guided preprocedural planning and ICE was conducted.
A prospective analysis of 71 non-consecutive patients who underwent LAAO over an 18-month period with cardiac CTA-guided preprocedural planning and ICE was conducted.
A prospective analysis of 71...
11/01/2021
Journal of Invasive Cardiology
Original Contribution
11/01/2021

Carmine Musto, PhD; Alberta Cifarelli, MD;  Francesco Dipasquale, MD; Diana Chin, PhD; Marco Stefano Nazzaro, PhD; Rocco Edoardo Stio, PhD; Mauro Pennacchi, PhD; Francesco De Felice, MD

Carmine Musto, PhD; Alberta Cifarelli...
Dr. Musto and colleagues evaluate the short- and long-term clinical and echocardiographic outcomes of the percutaneous closure of the patent foramen ovale (PFO) with an atrial septal aneurysm (ASA) using 2 different devices.
Dr. Musto and colleagues evaluate the short- and long-term clinical and echocardiographic outcomes of the percutaneous closure of the patent foramen ovale (PFO) with an atrial septal aneurysm (ASA) using 2 different devices.
Dr. Musto and colleagues...
11/01/2021
Journal of Invasive Cardiology
Original Contribution
11/01/2021

Azeem Latib, MD1,2;  Pierfrancesco Agostoni, MD, PhD3;  Jo Dens, MD, PhD4;  Mark Patterson, MBBS, PhD5;  Patrizio Lancellotti, MD, PhD6;  Frankie C.C. Tam, MD7;  Carl Schotborgh, MD8;  Elvin Kedhi, MD9;  Pieter Stella, MD, PhD10;
Cheryl Shen, MS11;  Gwenn Wetzels, PhD11;  Luca Testa, MD12; for the PREVAIL Study Investigators

Azeem Latib, MD1,2;  Pierfrancesco Ag...
The PREVAIL study evaluated the safety and effectiveness of a paclitaxel DCB for the treatment of coronary de novo and ISR lesions in patients with symptomatic ischemic heart disease.
The PREVAIL study evaluated the safety and effectiveness of a paclitaxel DCB for the treatment of coronary de novo and ISR lesions in patients with symptomatic ischemic heart disease.
The PREVAIL study evaluated the...
11/01/2021
Journal of Invasive Cardiology
Original Contribution
11/01/2021

Claudia Frankfurter, MD1; Annamalar M. Muthuppalaniappan, MBBS2; Ricardo Gorocica-Romero, MD2; Lusine Abrahamyan, MD, MPH, PhD3,4; Christopher Olesovsky, MD1; Jin Ma, PhD, MSc;Lee Benson, MD2,5; Mark Osten, MD2; Eric M. Horlick, MDCM2

Claudia Frankfurter, MD1; Annamalar M...
A retrospective analysis of consecutive patients who underwent concurrent percutaneous PFO closure and coronary angiography was performed.
A retrospective analysis of consecutive patients who underwent concurrent percutaneous PFO closure and coronary angiography was performed.
A retrospective analysis of...
11/01/2021
Journal of Invasive Cardiology
Original Contribution
11/01/2021

Dongliang Fu, MD1; Mengru Liu, MD2; Tong Gao, MD2; Chunyan Li, MD1; Jiangquan Liao, MD1; Mingjing Shao, MM1; Xiang Xiao, MD1; Peng Yang, MMed1; Xianlun Li, MD1; Hong Jiang, MD1

Dongliang Fu, MD1; Mengru Liu, MD2; T...
Dr. Fu and colleagues evaluated MACE and hemorrhagic event rates for an antithrombotic regimen using bivalirudin or UFH during PCI in ACS patients.
Dr. Fu and colleagues evaluated MACE and hemorrhagic event rates for an antithrombotic regimen using bivalirudin or UFH during PCI in ACS patients.
Dr. Fu and colleagues evaluated...
11/01/2021
Journal of Invasive Cardiology
Brief Contribution
11/01/2021

Francesco Ponticelli, MD1*;  Arif A. Khokhar, BM BCh1*;  Stefano Albani, MD2; Georgios Tzanis, MD3;  Francesco Gallo, MD1;  Stefano Guarracini, MD4;  Shmuel Banai, MD5;  Antonio Colombo, MD1;  Francesco Giannini, MD1

Francesco Ponticelli, MD1*;  Arif A. ...
Six mechanisms appear to explain poor response to coronary sinus reducer therapy. We hereby review these mechanisms in detail and highlight key areas that should be addressed in order to try and reduce the burden of non-responders following...
Six mechanisms appear to explain poor response to coronary sinus reducer therapy. We hereby review these mechanisms in detail and highlight key areas that should be addressed in order to try and reduce the burden of non-responders following...
Six mechanisms appear to explain...
11/01/2021
Journal of Invasive Cardiology
Original Contribution
11/01/2021

Ovidio De Filippo, MD1*; Fabrizio D’Ascenzo, MD1*; Filippo Angelini, MD1; Luca Franchin, MD1; Enrico Cerrato, MD2; Mauro Pennacchi, MD3; Ivan Nuñez-Gil, MD4; Wojciech Wojakowski, MD5; Yoichi Imori, MD6; Daniela Trabattoni, MD7; Zenon Huczek, MD8; Giuseppe Venuti, MD9; Saverio Muscoli, MD10; Mario Iannaccone, MD11; Andrea Montabone, MD1; Giorgio Marengo, MD1; Andrea Rognoni, MD1; Radoslaw Parma, MD5; Filippo Figini, MD13; Satoru Mitomo, MD14; Giacomo Boccuzzi, MD11; Alessio Mattesini, MD15; Giorgio Quadri, MD2; Wojciech Wańha, MD5; Grzegorz Smolka, Prof5; Cristina Rolfo, MD2; Bernardo Cortese, MD16; Nicola Ryan, MBBCh4; Davide Capodanno, Prof9; Alaide Chieffo, MD14; Carlo di Mario, Prof15; Ferdinando Varbella, MD2; Francesco Romeo, Prof10; Imad Sheiban, Prof13; Javier Escaned, Prof4; Gerard Helft, MD17; Gaetano M. De Ferrari, Prof1

Ovidio De Filippo, MD1*; Fabrizio D’A...
This study assesses the safety and efficacy of thin-strut stents in non-left main (non-LM) bifurcation coronary lesions.
This study assesses the safety and efficacy of thin-strut stents in non-left main (non-LM) bifurcation coronary lesions.
This study assesses the safety...
11/01/2021
Journal of Invasive Cardiology
Original Contribution
11/01/2021

Paola Scarparo, MD; Menno van Gameren, MD, PhD; Jeroen Wilschut, MD; Joost Daemen, MD, PhD; Wijnand K. Den Dekker, MD, PhD; Peter De Jaegere, MD, PhD; Felix Zijlstra, MD, PhD; Nicolas M. Van Mieghem, MD, PhD; Roberto Diletti, MD, PhD

Paola Scarparo, MD; Menno van Gameren...
We compared very long-term clinical outcomes in STEMI patients with either large or small thrombus burden.
We compared very long-term clinical outcomes in STEMI patients with either large or small thrombus burden.
We compared very long-term...
11/01/2021
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement